Beta
Company data is growing.
← All companies
/
Top lists
/
Gilead Sciences
Gilead Sciences
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
30 390
26 107
22 127
22 449
24 689
27 305
27 281
27 116
28 754
29 443
Operating profit (EBIT)
17 633
14 124
8 200
4 287
4 071
9 918
7 330
7 605
1 662
10 022
Net income attributable to shareholders
13 501
4 628
5 455
5 386
123
123
123
5 665
480
8 510
EBIT margin
58,0%
54,1%
37,1%
19,1%
16,5%
36,3%
26,9%
28,1%
5,8%
34,0%
Gross margin
86,0%
83,3%
78,1%
79,2%
81,5%
75,8%
79,3%
76,0%
78,3%
78,8%
Operating cash flow
16 669
11 898
8 400
9 144
8 168
11 384
9 072
8 006
10 828
10 019
Free cash flow
15 921
11 308
7 476
8 319
7 518
10 805
8 344
7 421
10 305
9 456
Cash
8 229
7 588
17 940
11 631
5 997
5 338
5 412
—
—
—
0
10 000
20 000
30 000
40 000
0,0%
20,0%
40,0%
60,0%
80,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
30 390
26 107
22 127
22 449
24 689
27 305
27 281
27 116
28 754
29 443
17 633
14 124
8 200
4 287
4 071
9 918
7 330
7 605
1 662
10 022